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Poor sleep qualityAbstract The present study aims to determine the prevalence of self-reported
sleep duration and sleep habits and their associated factors in patients with type
2 diabetes in Trinidad. This was a cross-sectional multicenter study. There were
291 patients with type 2 diabetes studied. Sleep habits were assessed using the
Epworth Sleepiness Scale (ESS) and the National Health and Nutrition Examination
Survey sleep disorder questionnaire. Demographic, anthropometric and biochemical
data were also collected. The sample had a mean age of 58.8 years; 66.7% were
female. The mean BMI was 28.9 kg/m2. The prevalence of Excessive Daytime
Sleepiness (EDS) was 11.3%. The prevalence of patients with short sleep (66 h)
was 28.5%. The prevalence of patients with poor sleep was 63.9%. Poor sleep was
associated with age, intensive anti-diabetic treatment and longer duration of dia-
betes. Short sleep was associated with intensive anti-diabetic treatment and BMI,
while EDS was associated with increased BMI. In a sample of patients with type 2 dia-
betes, a high prevalence of self-reported sleep duration and unhealthy sleep habits
S36 R. Ramtahal et al.was found. There needs to be an increased awareness of sleep conditions in adults
with type 2 diabetes by doctors caring for these patients.
ª 2015 Ministry of Health, Saudi Arabia. Published by Elsevier Ltd. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/
by-nc-nd/4.0/).1. Introduction
Sleep disorders have been associated with chronic
illnesses, mental disorders, restrictions in daily
functional capacity, and increases in injury and
mortality [1,2]. Excessive daytime sleepiness
(EDS), a common condition globally, has been
found to be strongly associated with obesity, meta-
bolic syndrome and diabetes, with diabetic
patients twice as likely to report EDS as their
non-diabetic counterparts [3]. It is also known that
sleep-related problems adversely affect metabolic
health [4]. Specifically, poor sleep and short sleep
have been associated with metabolic syndrome,
obesity, type 2 diabetes, hypertension and cardio-
vascular disease [5,6]. EDS has been shown to be a
predictor of severe hypoglycemia [7]. Importantly,
EDS is also associated with depression and poorer
health-related quality of life (HRQOL) [3,8]. Due
to these multiple adverse effects of sleep prob-
lems, sleep has become an emerging area of inves-
tigation in the area of modifiable factors affecting
the management of diabetes.
Most recent International Diabetes Federation
data estimate the number of persons with diabetes
in the world as 382 million [9]. Trinidad and Tobago
ranked sixth in the North American and Caribbean
(NAC) region in the number of diabetes cases in
2012. The age-adjusted prevalence of diabetes in
Trinidad and Tobago in the 20–79 year age group
is 13.9% [9].
There have been no studies, to the knowledge of
the researchers in the present study, examining the
burden of self-reported sleep duration and sleep
habits in patients with type 2 diabetes in the
Caribbean. This study aims to determine the preva-
lence of self-reported sleep duration and sleep
habits, and factors associated with these condi-
tions, in clinic patients with type 2 diabetes in
South Trinidad. This information is essential for
guiding strategies for sleep-related problems pre-
vention and intervention in diabetes patients in
this region.
2. Materials and methods
This was a cross-sectional, multicenter study car-
ried out at four governmental health facilities inthe South region of Trinidad. All type 2 diabetic
patients attending specialist diabetic outpatient
clinics over a four-month period in 2013 were
invited to participate in this study. During the study
period, 291 total patients were eligible for the
study and were invited to participate. All eligible
patients who were invited agreed to participate,
yielding a 100% response rate.
All participants signed an informed consent.
Exclusion criteria included: type 1 diabetes, less
than 18 years of age, pregnant, or refusal to sign
an informed consent form. This study was approved
by the Ethics Committee of the South West
Regional Health Authority (SWRHA), Trinidad.2.1. Sleep duration and sleep habits
2.1.1. Measurements
During the office visit, physicians administered the
following two existing questionnaires: the Epworth
Sleepiness Scale (ESS) and the National Health and
Nutrition Examination Survey (NHANES) 2007 Sleep
Disorders Questionnaire. The ESS is an eight-item
questionnaire that measures subjective sleepiness
[10]. An ESS score of >10 indicates the presence
of Excessive Daytime Sleepiness (EDS). The
NHANES 2007 Sleep Disorders Questionnaire [11]
is a 24-item questionnaire that assesses self-
reported physician diagnosis of a sleep disorder,
functional status outcomes for sleep disorders,
quality, and the number of sleep hours per night.
Using the answer to the question: ‘‘How much
sleep do you usually get at night on weekdays or
workdays?’’ patients were categorized as having
short sleep if they slept less than or equal to 6 h.
As it has been done in prior studies using the
NHANES questionnaire [12], patients were defined
as having poor sleep if they answered ‘‘often’’ or
‘‘almost always’’ (together defined as 5–30 times
a month) to any of the following six questions: (1)
In the past month, how often did you have trouble
falling asleep? (2) How often did you wake up dur-
ing the night and had trouble getting back to sleep?
(3) How often did you wake up too early in the
morning and were unable to get back to sleep?
(4) How often did you feel unrested during the
day, no matter how many hours of sleep you had?
(5) How often did you feel excessively or overly
Table 1 Characteristics of the study participants.
N = 291 (100%)
Age (years) 58.8 (11.2)
Age category, %
<50 19.6
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not get enough sleep? [12]. Lastly, also from the
NHANES Sleep Disorders Questionnaire, snoring
and individually, the following sleep-related diffi-
culties were analyzed: (1) Do you have difficulty
concentrating on the things you do because you
feel sleepy or tired? (2) Do you generally have dif-
ficulty remembering things because you are sleepy
or tired? (3) Do you have difficulty working on a
hobby, for example, sewing, collecting, or garden-
ing, because you are sleepy or tired? (4) Do you
have difficulty getting things done because you
are too sleepy or tired to drive or take public trans-
portation? (5) Do you have difficulty taking care of
financial affairs and doing paperwork (for example,
paying bills or keeping financial records) because
you are sleepy or tired? and (6) Do you have diffi-
culty performing employed or volunteer work
because you are sleepy or tired? The answers were
reported as any (when a participant answered ‘‘lit-
tle difficulty’’ or ‘‘moderate difficulty’’ or ‘‘ex-
treme difficulty’’), and as moderate or severe
(when the participant answered ‘‘moderate diffi-
culty’’ or ‘‘extreme difficulty’’).
Finally, the combined presence of self-reported
physician diagnosed sleep disorders, short sleep,
and poor sleep was assessed using mutually exclu-
sive categories.50–60 32.7
60–70 32.0
70+ 15.5
Female (%) 66.7
Race (%)
African 21.7
East Indian 74.6
Other 3.8
Duration of diabetes (years) 10 [6–19]
Medications for diabetes, %
None 0.7
Oral 30.2
Insulin 16.8
Both 46.72.2. Other measurements
Measurements were taken for height (m), weight
(kg), blood pressure (mmHg) and waist circumfer-
ence (cm). Medical charts were used to obtain
laboratory results within six months of the visit.
When available, values of HDL (mg/dl), LDL
(mg/dl), total cholesterol (mg/dl) and triglyc-
erides (mg/dl) were extracted. Ethnicity, age
and duration of diabetes were self-reported and
anti-diabetic medication use was recorded from
clinical notes.BMI (kg/m2) 28.9 (5.4)
WHO BMI category (%)
Underweight 1.4
Normal 19.6
Overweight 33.0
Obese 13.8
Waist circumference (cm) 99 [92.5–109]
SBP (mmHg) n = 104 150.5 (27.0)
DBP (mmHg) n = 104 80.7 (12.8)
Total cholesterol (mg/dl) n = 243 186.5 (50.9)
HDL-cholesterol (mg/dl) n = 236 48.2 (13.2)
LDL-cholesterol (mg/dl) n = 231 109.2 (39.7)
Triglycerides (mg/dl) n = 185 131 [96–197]
Data are presented as means (SD), medians [Percentile 25
and 75] or frequency.2.3. Statistical analyses
Descriptive statistics (means, medians or fre-
quency) were used to characterize the study sam-
ple overall. The overall prevalence of self-
reported, physician-diagnosed sleep disorder, short
sleep and poor sleep, alone or in combination, was
reported. To compare the characteristics of partic-
ipants by the sleep duration and EDS, T-test and
Chi-square test statistics were used for continuous
and categorical variables, respectively. Statistical
analyses were conducted using Stata 13 (College
Station, Tx).3. Results
Participant characteristics are presented in Table 1
for the total sample. Most study participants were
female (66.7%), and of East Indian origin (74.6%),
which is consistent with the demographics of the
region. The mean age was 58.8 (SD 11.2) years,
and the median duration of diabetes was 10 years.
Most patients were on both oral hypoglycemic
agents and insulin therapy (46.7%); 33% of patients
were overweight, while 13.8% were obese.
The overall prevalence of sleep-related disor-
ders and poor sleep habits, alone and in combina-
tion, and their median ESS are presented in
Table 2. The overall prevalence of self-reported,
physician-diagnosed sleep disorder was very low
(1.7%); however, the prevalence of short sleep
was very high (28.5%). More than two thirds of
the study participants (63.9%) were categorized
as having poor sleep. When the presence of
Table 2 Overall prevalence of sleep-related disorders and poor sleep habits and median Epworth Sleepiness Scale (ESS)
by category.
N (%) Median ESS
Self-reported, physician-diagnosed sleep disorder 5 (1.7%) 5
Poor sleep 186 (63.9%) 5.5
Short sleep (<6 h) 83 (28.5%) 6
Combination of sleep disorder, short sleep and poor sleep*
Sleep disorder, short sleep and poor sleep 2 (0.7%) 12.5
Sleep disorder and short sleep 0 –
Sleep disorder and poor sleep 3 (1%) 5
Sleep disorder only 0 –
Short sleep and poor sleep 66 (22.7%) 6
Short sleep only 15 (5.2%) 4
Poor sleep only 115 (39.5%) 5
None 90 (30.9%) 2
* Mutually exclusive categories.
S38 R. Ramtahal et al.self-reported sleep disorder, poor sleep and short
sleep was combined, it was found that almost
40% had only poor sleep, short sleep was relatively
uncommon in isolation (5.2%), and 22.7% reported
short and poor sleep together. EES scores were
higher among those with any sleep-related issue
compared to those without any issues.
3.1. Characteristics associated with short
sleep duration
The characteristics of the patients by sleep dura-
tion category are shown in Table 3. A trend was
found in the association between younger age and
short duration of sleep (p value = 0.06). In addi-
tion, those with more intensive diabetes treatment
with both insulin and oral anti-diabetic medica-
tions were more likely to report short sleep com-
pared to those with monotherapy (p value = 0.02).
There was also a significant association between
short sleep and increased BMI (p value = 0.05). No
significant associations were observed between
sleep duration and ethnicity, gender or duration
of diabetes or the biochemical parameters that
were measured.
3.2. Characteristics associated with
excessive daytime sleepiness
The median (percentile 25- percentile 75) ESS was
4 (2–8); 11.3% of patients reported having EDS.
The characteristics of patients according to EDS
status are presented in Table 4. There was a statis-
tically significant association between EDS and
higher BMI (p = 0.04). However, no other significant
differences were observed.3.3. Sleep quality
A majority (63.9%) of patients had poor sleep qual-
ity. Sleep quality was also significantly associated
with age category (p value = 0.05), with patients
between the ages of 50–70 years more likely to
report poor sleep (66%).
Poor sleep quality was also significantly associ-
ated with more intensive medication use
(p = 0.05) and duration of diabetes (p = 0.02). No
other significant associations were observed.
(Data not shown.).
3.4. Other sleep-related difficulties
Snoring was reported by 54.7% of patients, with
26.5% snoring for 5 or more days in the last
12 months; 17.9% of patients also reported snort-
ing, gasping or stopping breathing while asleep in
the past 12 months.
Figs. 1–3 present the prevalence of poor sleep-
related quality symptoms and difficulties, as well
as the distribution of the number of poor sleep-
related reported symptoms.
4. Discussion
This is one of the first studies to provide evidence
of the burden of sleep-related conditions among
patients with type 2 diabetes in the Caribbean
region. This study found a high prevalence of poor
sleep quality (63.9%) and short sleep (28.5%), while
EDS was less prevalent (11.3%). These prevalence
estimates are worrisome given the increasing evi-
dence of the role of sleep in health, in particular
among patients with diabetes.
Table 3 Characteristics of the study participants by duration of sleep.
Sleep duration > 6 h Sleep duration 6 6 h p Value
N = 208 (71.5%) N = 83 (28.5%)
Age (years) 59.6 (10.7) 56.7 (11.9) 0.06
Age category, % 0.13
<50 16.8 26.8
50–60 31.7 35.4
60–70 34.1 26.8
70+ 17.3 11.0
Female (%) 69.7 59.0 0.08
Race (%) 0.24
African 23.6 16.9
East Indian 73.6 77.1
Other 2.9 6.0
Duration of diabetes (years) 10 [6–17] 10 [6–20] 0.18
Medications for diabetes,% 0.02
None 0.5 1.3
Oral 37.1 19.2
Insulin 14.7 25.6
Both 47.7 53.9
BMI (kg/m2) 28.4 (5.1) 30.1 (5.9) 0.05
WHO BMI category (%) 0.58
Underweight 1.6 1.5
Normal 24.3 18.2
Overweight 38.9 36.4
Obese 35.1 43.9
Waist circumference (cm) 99 [93–109] 99.5 [92–110] 0.95
SBP (mmHg) n = 104 150.9 (26.5) 149.5 (28.7) 0.72
DBP (mmHg) n = 104 80.1 (13.2) 82.7 (11.3) 0.11
Total cholesterol (mg/dl) n = 243 185.4 (47.9) 189.4 (58.5) 0.62
HDL-cholesterol (mg/dl) n = 236 48.4 (13.3) 47.7 (13.0) 0.73
LDL-cholesterol (mg/dl) n = 231 109.5 (40.7) 108.4 (37.2) 0.84
Triglycerides (mg/dl) n = 185 124 [92–197] 150 [106–212] 0.23
Data presented as mean (SD), median [IQR] or %. For percentages, column adds 100%.
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with diabetes, it was found that the prevalence
of poor sleep in Trinidad was higher. Using the
same instrument as the present study, Liu et al.
found the prevalence of poor sleep to be 50.5% in
a selected adult population [13], and Bansil et al.
found the prevalence of poor sleep to be 52.1% in
an American population that consisted of 8% dia-
betic patients [12]. To the knowledge of the
researchers of the present study, this study is the
first one to use the NHANES sleep quality instru-
ment in exclusively diabetic patients, and for this
reason, it cannot be compared directly with other
studies conducted among people with type 2 dia-
betes that used other instruments to assess sleep-
related issues. Notwithstanding the lack of direct
comparability, these results are in overall agree-
ment with these studies that report a high preva-
lence of sleep-related issues among people withdiabetes. For example, using the Pittsburgh Sleep
Quality Index (PSQI), Mahmood et al. studied 114
individuals with type 2 diabetes in Ireland and
found that 44.7% had poor sleep quality [14].
Medeiros et al., using the same instrument in a
sample of 110 type 2 diabetic patients in Brazil,
found a prevalence of poor sleep quality in 53.3%
[15]. Cho et al., using the PSQI in a sample of 614
patients in Korea, found a prevalence of poor sleep
quality in 49% of type 2 diabetic patients [16],
while Lopes et al. found that 100 type 2 diabetic
patients in Brazil had poor sleep quality in 45% of
cases using the PSQI [17].
The findings of the present study regarding the
prevalence of short sleep are also somewhat in
agreement with prior studies [18–21]. Mahmood
et al. found that 19.3% of type 2 diabetics in
Ireland had short sleep (<6 h) [14]. In the general
population, the prevalence of EDS is estimated to
Table 4 Characteristics of the study participants by Excessive Daytime Sleepiness status.
Excessive daytime sleepiness no Excessive daytime sleepiness yes p Value
N = 258 (88.7%) N = 33 (11.3%)
Age (years) 59.1 (11.1) 56.5 (11.7) 0.22
Age category, % 0.34
<50 18.6 28.2
50–60 32.9 31.3
60–70 31.8 34.4
70+ 16.7 6.3
Female (%) 33.3 69.7 0.69
Race (%) 0.69
African 21.3 24.2
East Indian 75.2 69.7
Other 3.5 6.1
Duration of diabetes (years) 10 [6–20] 10 [5–15] 0.24
Medications for diabetes, % 0.16
None 0.4 3.5
Oral 33.3 20.7
Insulin 17.9 17.2
Both 48.4 58.6
BMI (kg/m2) 28.6 (5.4) 30.8 (4.9) 0.04
WHO BMI category (%) 0.15
Underweight 1.8 0
Normal 24.7 7.1
Overweight 37.7 42.9
Obese 35.9 50.0
Waist circumference (cm) 99 [92–109] 102 [97–112] 0.09
SBP (mmHg) n = 104 150.8 (25.2) 148.2 (38.9) 0.72
DBP (mmHg) n = 104 80.4 (12.6) 83.5 (14.7) 0.27
Total cholesterol (mg/dl) n = 243 185.7 (50.9) 193.9 (51.4) 0.46
HDL-cholesterol (mg/dl) n = 236 48.1 (12.2) 49.0 (20.5) 0.83
LDL-cholesterol (mg/dl) n = 231 108.3 (39.6) 118.2 (40.9) 0.30
Triglycerides (mg/dl) n = 185 126.5 [94–196] 159 [104–212] 0.31
Data presented as mean (SD), median [IQR] or %. For percentages, column adds 100%.
S40 R. Ramtahal et al.range from 5% to 20% [3,22–24]. Cho et al. showed
that the prevalence of EDS in type 2 diabetic
patients was 8.5% using the ESS [16], while Lopes
et al. found EDS in 26% of type 2 diabetic patients
using the ESS [17]. The highest prevalence was seen
in a study by Medeiros et al., which found that dia-
betic patients had EDS in 55.5% of cases, also using
the ESS [15].
The present study showed the prevalence of EDS
was 11.3%, as defined using the ESS questionnaire.
This is in the lower range compared with global
data. This may be due to cultural differences,
and validated ESS may be needed in this
population.
EDS can be associated with obstructive sleep
apnea (OSA) and its negative metabolic conse-
quences [1]. In addition; EDS may result in sleep-
related difficulties that eventually lead to
decreased job productivity and loss of employ-
ment. It can also lead to negative consequences,such as while driving or operation of heavy equip-
ment. Further studies need to be done to fully
assess the impact of EDS in this population.
It was found that younger age was associated
with short and poor quality sleep. One of the rea-
sons for these findings may be due to voluntary
sleep restriction. The advancement in technology
has been associated with an increase in leisure
activities, such as increased gaming activity on
mobile phones and laptop computers, online shop-
ping, use of social media and watching online
videos. The use of sleep education programs, cog-
nitive behavioral therapy, and medical treatment
may improve sleep hygiene in these patients and
may be one of the targets of treatment of type 2
diabetic patients with poor sleep duration and
quality.
This study also highlights a high prevalence of
functional disability (poor concentration, difficulty
remembering and difficulty in performing daily
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knowledge of the researchers in the present study,
no study has thoroughly assessed the extent of
sleep functional disability-related difficulties in
patients with type 2 diabetes. These results
demonstrate the high burden of these conditions
and highlight the need for more awareness, treat-
ment and research.This study also showed a high prevalence of
snoring (54.7%). This is higher than estimates
obtained in the American population (48%) [25].
Snoring is important as it is considered a marker
for OSA [1], and OSA has significant negative meta-
bolic effects. Given that there are existing thera-
peutic methods to improve OSA [1], more studies
using state-of-the art methods to diagnose OSA
Fig. 3 Distribution of poor sleep-related reported
symptoms.
S42 R. Ramtahal et al.are needed to confirm the high prevalence of OSA
in patients with type 2 diabetes and to target
treatment.
Significant associations were found between
short sleep duration, poor sleep quality and use
of anti-diabetic medication. These findings may
indirectly support the hypothesis of an association
between worse glycemic control and sleep distur-
bances. HbA1c is the gold standard biomarker of
glycemic control. However, challenges to the cur-
rent availability and accuracy of HbA1c data in
Trinidad have been observed and documented
[26]. In the present study, only non-standardized
HbA1c assays were available in a subset of individ-
uals and, therefore, these data could not be used in
the analyses.
Limitations of this study included the use of
questionnaire-based assessments to characterize
sleep-related issues. Clearly, future studies are
needed with state-of-the-art assessments.
Questionnaires developed in other study popula-
tions were also used which have not been validated
in Trinidad. The present study used a non-
representative sample in which only patients in
the south of Trinidad were studied, so the results
may not be generalizable to all type 2 diabetics
in the country. Standardized laboratory data were
lacking in order to examine the correlation
between glycemic control and sleep disorders.
Strengths of this study included being one of the
first studies in the region to thoroughly character-
ize sleep disorders and difficulties in a sample from
different communities in Trinidad.
These findings suggest a high prevalence of sleep
disorders in patients with type 2 diabetes in the
Caribbean region and highlight the need for subse-
quent studies. Future studies should evaluate the
metabolic and cardiovascular consequences of
these conditions and also address the awarenessof the disease. Nevertheless, this study recom-
mends that questions related to sleep habits be a
part of the routine history taking in these patients
and symptoms regarding sleep habits be actively
enquired about.
5. Conclusion
Poor sleep quality, unhealthy sleep habits and
sleep-related difficulties are highly prevalent
among patients with type 2 diabetes in Trinidad.
Sleep-related problems are associated with
increased cardiovascular and metabolic conse-
quences, and thus it is important to detect them.
There needs to be increased awareness and surveil-
lance of these sleep-related problems.Conflict of interest
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